|
Overview European Market
Market size: $90 billion
Market growth: 8% in constant local currency dollars
Market forecast 1998-2002:
- Western Europe: 6% CAGR
- Eastern Europe: 9% CAGR
Controlling healthcare expenditure
remained a high priority in 1999 for governments in Europe,
particularly for those joining the EMU, and pharmaceuticals
remain a high profile target. Cost-containment measures such
as promotion of generic prescribing, formularies and limiting
reimbursement are now in place in most countries. Supply controls
are being supplemented by demand controls, witnessed by a
growing trend towards shifting some of the financial burden
for drug costs from the state to the patient.
The EC continues to police national pricing policies. In 1999
it intervened in two important cases, a 6% price cut in Spain
and the Danish pay-back system.
The two largest European markets, Germany and France showed
lower than average growth rates for the region at 1% and 0%
respectively (with negative growth in US$ terms). Of the major
markets, UK experienced the highest growth rate of 8% followed
by the Spain at 6% in constant US$ terms.
Detailed
reports of sales for the Top 20 Corporations,
Products,
Countries
and Therapy
Areas in 1998 and 1999 are available to buy online.
*Source: World
Review 2000.
Please note Data
collection, values and definitions.
|
